Move your customers from retail CBD to prescription cannabidiol. We provide licensed clinicians, LegitScript Certified pharmacies, and prescription-strength dosing. You keep your brand and your customer list.
A licensed clinician decides every prescription · Live within weeks: clinicians and pharmacies already credentialed · Eligibility confirmed by shipping state at intake
total THC allowed per container after December 11; one dropper of a typical full-spectrum CBD oil already exceeds it.¹
THC in an entire 12,000 mg bottle of the prescription CBD, less than half a dropper of typical full-spectrum oil.⁴
of hemp-derived cannabinoid products sold today fall outside the new definition (industry estimate).²
LegitScript certifications available to ingestible retail CBD.³
Sources: 1. Federal hemp definition (CRS); Johnson et al., Drug & Alcohol Dependence, 2022 (median 0.64 mg THC/mL in THC-positive CBD oils) · 2. Wilson Elser, “The Great Hemp Reset,” 2026 · 3. LegitScript CBD Certification eligibility · 4. Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request; Johnson et al. 2022
On December 11, a new federal rule caps hemp products at 0.4 mg of total THC per container. One dropper of a typical full-spectrum CBD oil already goes over. Industry estimates put roughly 95% of hemp-derived cannabinoid products sold today outside the new definition.
The damage starts before the deadline. Payment processors and ad platforms are already pulling accounts. Legal counsel is flagging product-liability policies written for a product that’s about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory (Wilson Elser, 2026).
"We’re proud to partner with CareValidate. Their team brings professionalism, clear communication, and a collaborative approach that we truly appreciate. It’s a pleasure working with people who value strong partnerships and care about the work they do. We look forward to continuing to work with their team!"
You introduce the program through your existing storefront and customer list, with marketing assets supplied by Kazmira.
A clinician reviews the patient's intake and medications, asynchronously or by a live visit where state rules require one, and decides whether prescription cannabidiol is appropriate.
A LegitScript Certified pharmacy compounds the prescribed dose with Kazmira's THC-free cannabidiol and ships it under your brand.
Pharmacist check-ins, monthly refills, and dose adjustments when appropriate, all running through your storefront. Same customer relationship, a different level of care.
“The calls have already started. Operators who built real brands and real customer lists in the hemp space are being told by their payment processors that they have weeks, not years,”
Beyond processing, legal counsel is flagging product-liability policies written for a product that's about to be reclassified, shipments caught mid-transit, e-commerce delistings, and lenders asking about inventory.
Source: Wilson Elser, “The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage”
The demand your customers built isn’t going anywhere; it can no longer be served over the counter. The prescription pathway is regulated under pharmacy law rather than the hemp definition, so neither the November 12 nor the December 11 deadline touches it.
Beyond December 11, a better reason for customers to choose you: most retail CBD leaves the customer to figure out the product, the dose and the results on their own. A typical serving holds 5 to 20 mg. Most positive clinical trials used more than 300 mg a day (Chesney et al., 2020), and about 7 in 10 CBD products sold online are mislabeled (Bonn-Miller et al., JAMA, 2017).
Retail CBD: low-dose products · guessing at the dose · labels that often miss (about 7 in 10 online products) · no medication screening · no clinical follow-up · no plan when CBD “doesn’t work”
A prescription turns CBD into a care plan: 200 to 400 mg prescribed daily doses · a licensed clinician reviewing their health and medications · drug-interaction screening before every prescription · pharmacy-compounded cannabidiol · pharmacist and clinician follow-up · dose adjustment when appropriate, with monthly refills
Plant to prescription: the CBD your customers came looking for, with a clinician and a pharmacist behind every dose.
Purity block (CBD in a class of its own): Purity matters when CBD becomes a prescription. Kazmira’s proprietary purification process was developed over more than a decade to produce cannabidiol at pharmaceutical standards.
Within 3% of label claim in independent testing of the referenced batch.*
29 steps of proprietary purification, developed by Kazmira’s founders, trained in the oil & gas industry as chemical engineers.†
cGMP · ICH Q7 · ISO 9001 manufacturing standards for drug ingredients.
3 strengths: 6,000, 9,000 and 12,000 mg bottles, one for each prescribed daily dose.
* Certificate of Analysis, Triverity Laboratories (ISO/IEC 17025 accredited), batch 2298453, Sep 2026, available on request.
† Refining crude oil means separating thousands of similar molecules into pure fractions. Kazmira’s founders learned that work as chemical engineers in oil and gas, then spent more than a decade applying it to the 100+ compounds in cannabis.
Keep your customers. Your existing customers are the first people you invite. Start before December 11.
Keep your brand. Patients order on your storefront, get support in your name, and receive their prescription under your brand. API-first, so it runs alongside the systems you already have.
Revenue that renews every month. Approved patients refill monthly, as prescribed, through your storefront.
Your patients stay yours. The customer relationship belongs to your storefront. Kazmira fills the prescriptions and doesn’t market to your patients.
Clinicians who know cannabidiol. Training in Kazmira’s clinical protocols (dosing, titration and drug-interaction screening) is available to every prescriber in your network.
A storefront that stands apart. Retail competitors sell another bottle. You offer a prescription program with a clinician and a pharmacist behind it.
API manufacturing, a licensed 503A compounding pharmacy, and a clinician-led telehealth platform, under one roof.
Kazmira, founded in 2016, now runs the nation's first 503A compounding pharmacy dedicated to prescription-only, THC-free CBD, launched January 2026.
Kazmira developed the method to remove every detectable trace of THC from cannabidiol at scale: 29 steps of proprietary purification under cGMP, ICH Q7 and ISO 9001 standards.
Independent testing of the referenced batch found less than 0.3 mg of THC in a 12,000 mg bottle, and potency within 3% of label claim (Certificate of Analysis, Triverity Laboratories, ISO/IEC 17025, available on request). Three strengths: 6,000, 9,000 and 12,000 mg bottles, one for each prescribed daily dose.
Verifiable at legitscript.com. Ingestible retail CBD is not eligible for this certification.
Pharmaceutical-grade API manufactured and third-party tested domestically.
Quoted in Forbes Health and Denver7; covered by MediaPost, FOX31, the Denver Gazette, Cannabis Business Times and MDLinx; featured in MedCity News.
OneCannabis, Kazmira’s education platform for clinicians and patients, launched in April 2026 with dosing and drug-interaction protocols built over 18 months.
LegitScript Certified pharmacy fulfillment. Kazmira Pharmacy and its licensed partner hold the state licenses and fill every order, with eligibility confirmed by shipping state at intake.
Licensed clinician network. Credentialed clinicians review each patient and decide whether to prescribe.
Pharmaceutical-grade, THC-free cannabidiol API. Purified by Kazmira in Watkins, Colorado, and third-party tested.
Compounding and shipping. The pharmacy compounds each patient's dose and ships it to their door.
Pre-approved marketing assets from Kazmira. Ads, images and claim language, cleared by Kazmira before they reach you.
White-label patient support. Patient questions answered under your brand's name.
Analytics and performance monitoring. Ongoing monitoring and reporting on your program's performance.
API-first integration. Connects to the storefront, EHR and fulfillment stack you already run.
Book a demo and we’ll plan your launch before the deadline, whether you’re moving an existing hemp/CBD brand or launching fresh.
Not all patients are eligible. No guarantee of prescription or outcome. Compounded medications are not FDA-approved. Educational information only; not medical advice.
